AETHLON MEDICAL INC (AEMD) › Net IncomeAETHLON MEDICAL INC (AEMD) — Net IncomeAnnual figures by period end, from SEC filings.2011-03-31: -$5.71M2012-03-31: -$8.11M2013-03-31: -$4.89M2014-03-31: -$13.36M2015-03-31: -$6.80M2016-03-31: -$4.87M2017-03-31: -$7.28M2018-03-31: -$5.68M2019-03-31: -$6.19M2020-03-31: -$6.37M2021-03-31: -$7.89M2022-03-31: -$10.42M2023-03-31: -$12.03M2024-03-31: -$12.21M2025-03-31: -$13.39M2026-03-31: -$7.15M-$7.15M2011-03-31Net Income (USD)2026-03-31Period endedNet IncomeChange YoYSource filing2026-03-31-$7.15M—2026-06-10From 2025-04-012025-03-31-$13.39M—2026-06-10From 2024-04-012024-03-31-$12.21M—2025-06-26From 2023-04-012023-03-31-$12.03M—2024-06-27From 2022-04-012022-03-31-$10.42M—2023-06-28From 2021-04-012021-03-31-$7.89M—2022-06-28From 2020-04-012020-03-31-$6.37M—2021-06-24From 2019-04-012019-03-31-$6.19M—2020-06-25From 2018-04-012018-03-31-$5.68M—2019-07-01From 2017-04-012017-03-31-$7.28M—2018-06-08From 2016-04-012016-03-31-$4.87M—2017-06-28From 2015-04-012015-03-31-$6.80M—2016-06-29From 2014-04-012014-03-31-$13.36M—2015-07-13From 2013-04-012013-03-31-$4.89M—2014-07-15From 2012-04-012012-03-31-$8.11M—2013-07-15From 2011-04-012011-03-31-$5.71M—2012-06-29From 2010-04-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)